Multiple Myeloma in Chronic Kidney Disease

نویسنده

  • A. Doyle
چکیده

Introduction: The incidence of multiple myeloma (MM) has increased in Scotland over the last 20 years. Approximately 25% of cases present directly to renal services. Serum electrophoresis is commonly included in the diagnostic screening tests performed in patients with chronic kidney disease (CKD). We examined the utility of serum electrophoresis in the population presenting to renal outpatient services in Glasgow. Methods: All new patient attendances at general nephrology clinics in the Glasgow renal units between 1/08/2004 and 31/07/2006, along with clinical data, were retrieved from the electronic patient records. Patients with acute kidney injury were excluded. All serum and urine electrophoresis requests and results for the same period were identified from Biochemistry and Immunology Laboratory Services. Results: A total of 2,544 new patients attended a renal clinic for the first time in the inception period, of whom 1,608 (63.2%) had serum electrophoresis tested. One patient with MM was identified, but the diagnosis was clinically apparent before the serum electrophoresis result was requested. A further 40 subjects had abnormal serum electrophoresis with mean paraprotein of 8.3 g/l (SD 6.1); none of these patients have subsequently developed MM, and the renal Received: March 19, 2008 Accepted: July 3, 2008 Published online: November 22, 2008 A. Doyle Renal Unit , Queen Margaret Hospital Whitefield Rd. Dunfermline, KY12 0SU (UK) Tel. +44 1383 623 623, Fax +44 1383 627 096, E-Mail [email protected] © 2008 S. Karger AG, Basel 1660–2110/09/1111–0007$26.00/0 Accessible online at: www.karger.com/nec Doyle /Soutar /Geddes Nephron Clin Pract 2009;111:c7–c11 c8 gree of renal failure at presentation is generally moderate and reversible in up to 50% of patients, particularly when it is related to precipitating factors such as hypercalcemia [8–11] . The British Committee for Standards in Haematology currently suggest a pathway of screening for the presence of paraproteins that is depicted in figure 1 . The initial step is to perform serum and urine electrophoresis, progressing to immunoelectrophoresis and then to isoelectric focusing and immunofixation, in order to better define any suspected paraprotein identified [12] . The aim of this retrospective study was to determine the utility of electrophoresis as a screening test in the population presenting to renal outpatient services in Glasgow.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Successful Treatment of Monoclonal Gammopathy of Renal Significance With Bortezomib in the Setting of Post- Viral SARs-CoV-2 Infection: Case Report

Introduction: Monoclonal Gammopathy of Renal Significance (MGRS) is an immunoglobulin proliferative disorder that leads to the destruction of the renal glomerular basement membrane and progression to end-stage renal disease. The pathogenesis of MGRS is similar to that of multiple myeloma and chronic lymphocytic lymphoma but lacks criteria for either disease. This inability to characterize the d...

متن کامل

Renal impairment and use of nephrotoxic agents in patients with multiple myeloma in the clinical practice setting in the United States

Renal impairment is a common complication of multiple myeloma and deterioration in renal function or renal failure may complicate clinical management. This retrospective study in patients with multiple myeloma using an electronic medical records database was designed to estimate the prevalence of renal impairment (single occurrence of estimated glomerular filtration rate [eGFR] <60 mL/min per 1...

متن کامل

Kidney Transplantation in Patients With Active Multiple Myeloma: Case Reports

Kidney disease is a common complication in patients with multiple myeloma. Traditionally, patients with active multiple myeloma and end-stage renal disease have been excluded from kidney transplantation due to the risk of malignancy progression. The introduction of bortezomib-based therapy for patients with multiple myeloma and renal impairment has significantly improved survival in this popula...

متن کامل

Severe hyperphosphatemia in a patient with chronic kidney disease and multiple myeloma–to strengthen the case toward renal replacement therapy?

KEY CLINICAL MESSAGE We report a patient with multiple myeloma and chronic kidney disease who presented with severe hyperphosphatemia in the outpatient clinic without any related symptoms. Initial differential diagnosis: Tumor lysis syndrome or chronic kidney disease. Further work-up revealed pseudohyperphosphatemia. In general, treatment is not necessary if the true phosphate level is within t...

متن کامل

Pathogenesis of Renal Failure in Multiple Myeloma: Any Role of Contrast Media?

The spectrum of kidney disease-associated monoclonal immunoglobulin and plasma cell malignancies is remarkably broad and encompasses nearly all nephropathologic entities. Multiple myeloma with kidney impairment at presentation is a medical emergency since the recovery of kidney function is associated with survival benefits. In most cases, kidney impairment may be the first clinical manifestatio...

متن کامل

Mandibular Swelling as the First Manifestation of Multiple Myeloma

Multiple myeloma is a monoclonal malignant proliferation of plasma cells. The disease is more frequent in men, and the average age of patients at the time of diagnosis of the disease is about 60 years. Solitary myeloma may be the first manifestation of the disseminated form of multiple myeloma, which is characterized by multiple skeletal lesions, general metabolic alterations, impairment of ren...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2008